Yahoo
HKSE - Delayed Quote HKD

Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)

7.385 +0.090 (+1.23%)
At close: October 30 at 4:08:06 PM GMT+8
Chart Range Bar
Loading chart for 1858.HK
  • Previous Close 7.295
  • Open 7.360
  • Bid 7.340 x --
  • Ask 7.385 x --
  • Day's Range 7.285 - 7.495
  • 52 Week Range 7.010 - 20.820
  • Volume 379,250
  • Avg. Volume 594,737
  • Market Cap (intraday) 2.822B
  • Beta (5Y Monthly) -0.28
  • PE Ratio (TTM) 9.23
  • EPS (TTM) 0.800
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.40 (5.45%)
  • Ex-Dividend Date May 28, 2026
  • 1y Target Est 17.95

Beijing Chunlizhengda Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China and internationally. The company offers orthopedic medical devices and tissue repair products, including spine, trauma, joint, sports medicine, and bone repair material implants; surgical instrumentation products; platelet-rich plasma preparation kits; and closed wound negative pressure drainage kits. It also provides surgical robots; joint, spinal, sports medicine, trauma, oral care, and endoscopic products; orthopedic power products; and platelet-rich plasma preparation system products, as well as alloy materials and surgical powering equipment. The company exports its products to approximately 68 countries. The company was formerly known as Chunli Limited and changed its name to Beijing Chunlizhengda Medical Instruments Co., Ltd. in September 2010. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.

www.clzd.com

841

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1858.HK
49.39%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

1858.HK
54.05%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

1858.HK
41.84%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

1858.HK
53.80%
HANG SENG INDEX (^HSI)
8.21%

Analyst Insights

View More

Analyst Price Targets

15.06
17.95 Average
7.385 Current
20.83 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.51%

  • Return on Assets (ttm)

    5.04%

  • Return on Equity (ttm)

    9.33%

  • Revenue (ttm)

    975.27M

  • Net Income Avi to Common (ttm)

    278.03M

  • Diluted EPS (ttm)

    0.800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.13B

  • Total Debt/Equity (mrq)

    0.10%

  • Levered Free Cash Flow (ttm)

    162.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: